Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03435887 · ClinicalTrials.gov registry record · NA
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
A NA study of HIV Infections, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,999
- Enrollment target
- 5
- Study locations
NCT03435887: Completed NA study of HIV Infections, sponsored by University of Kansas Medical Center.
NCT03435887 is a NA study of HIV Infections that has completed, run by University of Kansas Medical Center. The registered enrollment target is 1,999 participants, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (352% higher). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03435887, a NA study of HIV Infections, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,999 participants
- Enrollment target
- 5
- Study locations
Study Summary
Innovative strategies to expedite HIV diagnosis among exposed infants, including at-birth testing and two portable point-of-care (POC) diagnostic systems, will be piloted using an implementation framework. The programmatic impact of these tools on early infant diagnosis (EID) will be measured in comparison with parallel standard of care (SOC) HIV DNA PCR testing initiated at 6 weeks of age.
Primary Outcome
The proportion of infants receiving HIV testing (POC and/or PCR) during the birth testing window
Conditions Studied
Interventions
- BEHAVIORAL Alere q HIV-1/2 Detect for point of care infant testing
- BEHAVIORAL GeneXpert HIV-1 Qual for point of care infant testing
- BEHAVIORAL HIV DNA PCR testing (Standard of Care)
Study Locations (5)
Other
- Kisumu County Hospital - Kisumu
- Kombewa District Hospital - Kombewa
- Tudor Sub-County Hospital - Mombasa
- Rift Valley Provincial General Hospital - Nakuru
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,999 participants |
| Start Date | 2016-12-02 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
What the finished NCT03435887 record still lists
NCT03435887 is an interventional study that assigns participants to a tested intervention. Its 1,999 participants enrollment target places it among the larger protocols in the corpus, above the 442-participant average among 542 other HIV Infections trials with a reported enrollment target (352% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Alere q HIV-1/2 Detect for point of care infant testing is the first listed.
NCT03435887 lists 5 locations in 2 states (Other, Kansas).
Frequently Asked Questions
What is clinical trial NCT03435887 about?
NCT03435887 is a clinical study titled "Piloting At-birth Point of Care HIV Testing Strategies in Kenya". Innovative strategies to expedite HIV diagnosis among exposed infants, including at-birth testing and two portable point-of-care (POC) diagnostic systems, will be piloted using an implementation framework. The programmatic impact of these tools on early infant diagnosis (EID) will be measured in com...
What is the current status of trial NCT03435887?
This trial is currently completed. It is a NA study. The enrollment target is 1,999 participants. The study started on 2016-12-02. Estimated completion is 2020-04-30.
What conditions does trial NCT03435887 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT03435887?
The interventions under investigation include: Alere q HIV-1/2 Detect for point of care infant testing (BEHAVIORAL), GeneXpert HIV-1 Qual for point of care infant testing (BEHAVIORAL), HIV DNA PCR testing (Standard of Care) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03435887?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03435887 being conducted?
This trial has 5 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03435887's enrollment target sits among peer trials
1,999 13th of 542 higher than 530 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI